Get paid to attend live sports events. Los candidatos deben tomarse el tiempo de leer atentamente todos los elementos de este anuncio de empleo. Por favor, envíen su solicitud sin demora. Were expanding our team across
Principal Biostatistician | Clinical Trials | (FSP - Pharma company) No espere a enviar su solicitud después de leer esta descripción; se espera un gran volumen de candidaturas para esta oportunidad. Immunology Phase II/III Who will
Principal Biostatistician | Clinical Trials | (FSP - Pharma company) Immunology Phase II/III Who will you be working with? This global CRO that offers flexible Functional Service Provider (FSP) solutions to a diverse range of clients
Social Discovery Group (SDG) is a group of social discovery companies. SDG solves the problems of loneliness, isolation, and disconnection - transforming virtual intimacy into the new normal. SDG’s products redefine the way people interact and
Principal Biostatistician | Global CRO | Home Based | Spain | Permanent | Siga leyendo para descubrir lo que necesitará para tener éxito en este puesto, incluyendo habilidades, cualificaciones y experiencia. We are partnering with a
Ready for your next career move? With continued business growth and a strong pipeline of new projects, Veramed is creating new opportunities for Statistical Programmers to work on innovative studies, expand their skills and advance their
Principal Biostatistician | Global CRO | Home Based | Spain | Permanent | We are partnering with a leading global CRO to recruit an experienced Principal Biostatistician to join their growing biometrics team. This is an
Social Discovery Group (SDG) is a group of social discovery companies. SDG solves the problems of loneliness, isolation, and disconnection - transforming virtual intimacy into the new normal. SDG’s products redefine the way people interact and
(Last day to apply: Sunday, September 20) About us Legit.Health deploys computer vision and artificial intelligence medical devices to enable lifesaving diagnosis and therapies for visible diseases. Our goal is to enable universal access to high-quality